Table 2. Multivariate Cox proportional hazard analysis of CDC25C gene expression for bladder cancer patients undergoing radical cystectomy.
Data set | Covariate | HR | 95% CI | P-value |
---|---|---|---|---|
MD Anderson (n = 37) | CDC25C | 2.26 | 1.04–5.40 | 0.0382 |
T3,4 vs. T1,2 | 4.08 | 0.98–28.7 | 0.0536 | |
N+ vs. N0 | 1.2 | 0.39–4.22 | 0.7594 | |
Chungbuk (n = 135) | CDC25C | 1.68 | 1.03–2.70 | 0.0396 |
T3,4 vs. T1,2 | 6.98 | 2.56–16.9 | 0.0004 | |
N+ vs. N0 | 1.43 | 0.37–4.90 | 0.584 | |
Lund (n = 224) | CDC25C | 2.27 | 1.05–4.77 | 0.038 |
T3,4 vs. T1,2 | 5.86 | 1.92–14.9 | 0.0037 |
Pathologic tumor and nodal stages and CDC25C gene expression were included as covariates for bladder cancer patients undergoing radical cystectomy without perioperative chemotherapy. Tumor stage and nodal stage were considered binary variables; CDC25C gene expression was considered a continuous variable. HR, hazard ratio; 95% CI, confidence interval. Nodal staging was excluded from analysis of the Lund data set due to insufficient data.